
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $10M | $2.8M | $9.8K | |
Revenue Growth (YoY) | -- | -- | -- | -71.92% | -99.65% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $20.8M | $30.6M | $30M | $21.5M | $14.2M | |
Selling, General & Admin | $6.6M | $8.5M | $11.2M | $12.1M | $9.2M | |
Other Inc / (Exp) | $1.5K | $372.4K | $437.8K | $778.5K | $19.4M | |
Operating Expenses | $27.4M | $39.1M | $41.4M | $33.7M | $23.5M | |
Operating Income | -$27.4M | -$39.1M | -$31.4M | -$30.9M | -$23.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | |
Basic EPS (Cont. Ops) | -$10.92 | -$7.56 | -$4.44 | -$4.15 | -$0.48 | |
Diluted EPS (Cont. Ops) | -$10.92 | -$7.56 | -$4.44 | -$4.15 | -$0.48 | |
Weighted Average Basic Share | $2.5M | $5.1M | $7M | $7.3M | $8.5M | |
Weighted Average Diluted Share | $2.5M | $5.1M | $7M | $7.3M | $8.5M | |
EBITDA | -$27.4M | -$39M | -$31.4M | -$30.9M | -$23.4M | |
EBIT | -$27.4M | -$39.1M | -$31.4M | -$30.9M | -$23.5M | |
Revenue (Reported) | -- | -- | $10M | $2.8M | $9.8K | |
Operating Income (Reported) | -$27.4M | -$39.1M | -$31.4M | -$30.9M | -$23.5M | |
Operating Income (Adjusted) | -$27.4M | -$39.1M | -$31.4M | -$30.9M | -$23.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $9.3K | $25.4K | |
Revenue Growth (YoY) | -- | -- | -- | -- | 173.35% | |
Cost of Revenues | -- | -- | -- | $7.7K | -- | |
Gross Profit | -- | -- | -- | $1.6K | $25.4K | |
Gross Profit Margin | -- | -- | -- | 17.5% | -- | |
R&D Expenses | $5.7M | $5.8M | $5M | $3.4M | $2.3M | |
Selling, General & Admin | $2M | $2.6M | $3.4M | $2.7M | $2.3M | |
Other Inc / (Exp) | $369.9K | $1.8K | $340.2K | -$732.9K | $202.8K | |
Operating Expenses | $7.7M | $8.4M | $8.4M | $6M | $4.6M | |
Operating Income | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Basic EPS (Cont. Ops) | -$1.92 | -$1.20 | -$1.08 | -$0.81 | -$0.50 | |
Diluted EPS (Cont. Ops) | -$1.92 | -$1.20 | -$1.08 | -$0.81 | -$0.50 | |
Weighted Average Basic Share | $3.7M | $7M | $7.1M | $8.4M | $8.8M | |
Weighted Average Diluted Share | $3.7M | $7M | $7.1M | $8.4M | $8.8M | |
EBITDA | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.4M | |
EBIT | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M | |
Revenue (Reported) | -- | -- | -- | $9.3K | $25.4K | |
Operating Income (Reported) | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M | |
Operating Income (Adjusted) | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $25.9K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $24.1M | $30.7M | $29.3M | $19.9M | $13.2M | |
Selling, General & Admin | $6.7M | $9.1M | $12M | $11.4M | $8.8M | |
Other Inc / (Exp) | $369.6K | $4.3K | $776.1K | -$294.5K | $20.3M | |
Operating Expenses | $30.8M | $39.8M | $41.4M | $31.4M | $22M | |
Operating Income | -$30.8M | -$39.8M | -$31.4M | -$28.6M | -$22M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$30.5M | -$39.8M | -$30.6M | -$28.9M | -$1.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$30.5M | -$39.8M | -$30.6M | -$28.9M | -$1.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$30.5M | -$39.8M | -$30.6M | -$28.9M | -$1.7M | |
Basic EPS (Cont. Ops) | -$10.68 | -$7.68 | -$4.26 | -$3.82 | -$0.17 | |
Diluted EPS (Cont. Ops) | -$10.68 | -$7.68 | -$4.26 | -$3.82 | -$0.18 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$30.8M | -$39.8M | -$31.3M | -$28.5M | -$21.8M | |
EBIT | -$30.8M | -$39.8M | -$31.4M | -$28.6M | -$22M | |
Revenue (Reported) | -- | -- | -- | -- | $25.9K | |
Operating Income (Reported) | -$30.8M | -$39.8M | -$31.4M | -$28.6M | -$22M | |
Operating Income (Adjusted) | -$30.8M | -$39.8M | -$31.4M | -$28.6M | -$22M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $9.3K | $25.4K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $7.7K | -- | |
Gross Profit | -- | -- | -- | $1.6K | $25.4K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $5.7M | $5.8M | $5M | $3.4M | $2.3M | |
Selling, General & Admin | $2M | $2.6M | $3.4M | $2.7M | $2.3M | |
Other Inc / (Exp) | $369.9K | $1.8K | $340.2K | -$732.9K | $202.8K | |
Operating Expenses | $7.7M | $8.4M | $8.4M | $6M | $4.6M | |
Operating Income | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Basic EPS (Cont. Ops) | -$1.92 | -$1.20 | -$1.08 | -$0.81 | -$0.50 | |
Diluted EPS (Cont. Ops) | -$1.92 | -$1.20 | -$1.08 | -$0.81 | -$0.50 | |
Weighted Average Basic Share | $3.7M | $7M | $7.1M | $8.4M | $8.8M | |
Weighted Average Diluted Share | $3.7M | $7M | $7.1M | $8.4M | $8.8M | |
EBITDA | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.4M | |
EBIT | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M | |
Revenue (Reported) | -- | -- | -- | $9.3K | $25.4K | |
Operating Income (Reported) | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M | |
Operating Income (Adjusted) | -$7.7M | -$8.4M | -$8.4M | -$6M | -$4.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $4.7M | $51.7M | $34.7M | $10.5M | $15.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $1.9M | $2.5M | $6.7M | $6.1M | $2.5M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $7M | $55.3M | $43M | $17.5M | $18.4M | |
Property Plant And Equipment | $277.5K | $242.7K | $522.8K | $2M | $2.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $254.3K | $599.6K | $1.1M | |
Total Assets | $7.6M | $55.8M | $43.8M | $21.3M | $22.1M | |
Accounts Payable | $1M | $2.1M | $2M | $3.4M | $1.5M | |
Accrued Expenses | $2.2M | $1.6M | $9.2M | $1.8M | $2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $347.7K | $270.6K | $398.4K | $468.7K | $548.6K | |
Other Current Liabilities | $1M | -- | -- | -- | -- | |
Total Current Liabilities | $7.7M | $16.1M | $31.6M | $20.5M | $21.6M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $8.7M | $17.1M | $32.7M | $26.3M | $28.1M | |
Common Stock | $4.2K | $8.4K | $8.5K | $830 | $870 | |
Other Common Equity Adj | -$91.4K | -$155K | -$351.3K | -$360.9K | -$428.8K | |
Common Equity | -$1.2M | $38.8M | $11.1M | -$5M | -$6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$1.2M | $38.8M | $11.1M | -$5M | -$6M | |
Total Liabilities and Equity | $7.6M | $55.8M | $43.8M | $21.3M | $22.1M | |
Cash and Short Terms | $4.7M | $51.7M | $34.7M | $10.5M | $15.7M | |
Total Debt | $367.3K | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.7M | $39.3M | $19.8M | $3.6M | $10.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $1.6M | $6.8M | $7.1M | $4.8M | $1.4M | |
Other Current Assets | -- | -- | $201.4K | $152.2K | -- | |
Total Current Assets | $9.6M | $47.8M | $29.5M | $10M | $11.8M | |
Property Plant And Equipment | $31.5K | $25.4K | $55.4K | $1.6M | $5.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $887.9K | $1.3M | $799.3K | $654.5K | $1.1M | |
Total Assets | $10.5M | $49.2M | $30.4M | $13M | $18.6M | |
Accounts Payable | $1.5M | $2.8M | $2.7M | $4M | $1.9M | |
Accrued Expenses | $2.5M | $3.5M | $5.5M | $1.4M | $1.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $444.5K | $294.5K | $335.8K | $470.4K | $2.3M | |
Other Current Liabilities | $1M | -- | -- | -- | $91.9K | |
Total Current Liabilities | $6.1M | $16.4M | $24.3M | $17.7M | $21.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $7.3M | $18.3M | $25.4M | $24M | $28.2M | |
Common Stock | $4.7K | $8.4K | $8.6K | $10.1K | $890 | |
Other Common Equity Adj | -$98.2K | -$164.1K | -$373.3K | -$400.1K | -$415.7K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3.3M | $30.9M | $5M | -$11M | -$9.6M | |
Total Liabilities and Equity | $10.5M | $49.2M | $30.4M | $13M | $18.6M | |
Cash and Short Terms | $7.7M | $39.3M | $19.8M | $3.6M | $10.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | |
Depreciation & Amoritzation | $43.2K | $26.4K | $24.2K | $38.4K | $42.3K | |
Stock-Based Compensation | $742K | $1.6M | $2.2M | $2.5M | $2.2M | |
Change in Accounts Receivable | $95K | -$685.2K | -$557.8K | $754K | $719.2K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$25.2M | -$28.8M | -$18.1M | -$38.9M | $5.4M | |
Capital Expenditures | $17.6K | $14.5K | $63.1K | $629.4K | $573K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$17.6K | -$14.5K | -$63.1K | -$629.4K | -$573.1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $367.3K | -- | -- | $601.2K | $561.7K | |
Long-Term Debt Repaid | -- | -- | -- | -$334K | -$579.2K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | $4.7M | -$2.2K | |
Cash From Financing | $25.1M | $75.8M | $1.3M | $15.6M | $433.8K | |
Beginning Cash (CF) | $4.8M | $4.7M | $51.7M | $34.7M | $10.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$121.9K | $47.1M | -$16.8M | -$23.8M | $5.3M | |
Ending Cash (CF) | $4.7M | $51.7M | $34.7M | $10.8M | $16M | |
Levered Free Cash Flow | -$25.3M | -$28.8M | -$18.2M | -$39.5M | $4.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Depreciation & Amoritzation | $6.4K | $5.2K | $9.5K | $10.8K | $158.1K | |
Stock-Based Compensation | $365.9K | $532.4K | $624.6K | $627.7K | $377.4K | |
Change in Accounts Receivable | $158.3K | -$584.5K | -$695.6K | -$436.5K | $124.8K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$8.4M | -$12.3M | -$16.1M | -$6.8M | -$5.5M | |
Capital Expenditures | -- | $4.6K | -- | $7.3K | $157.3K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$4.6K | -- | -$7.3K | -$157.3K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$200.4K | -$187.2K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$690 | -$2.5K | |
Cash From Financing | $11.4M | -- | $1.3M | $14K | $246.6K | |
Beginning Cash (CF) | $4.7M | $51.7M | $34.7M | $10.8M | $16M | |
Foreign Exchange Rate Adjustment | -$6.8K | -$9.2K | -$22K | -$39.2K | $13.1K | |
Additions / Reductions | $3M | -$12.3M | -$14.8M | -$6.8M | -$5.4M | |
Ending Cash (CF) | $7.7M | $39.3M | $19.8M | $4M | $10.6M | |
Levered Free Cash Flow | -$8.4M | -$12.3M | -$16.1M | -$6.8M | -$5.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$30.5M | -$39.8M | -$30.6M | -$28.9M | -$1.7M | |
Depreciation & Amoritzation | $37.7K | $25.2K | $28.5K | $39.6K | $189.7K | |
Stock-Based Compensation | $947.1K | $1.8M | $2.3M | $2.5M | $2M | |
Change in Accounts Receivable | $127.9K | -$1.4M | -$668.9K | $1M | $1.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$27M | -$32.7M | -$21.9M | -$29.6M | $6.7M | |
Capital Expenditures | $17.6K | $19.1K | $58.5K | $636.7K | $723.1K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$17.6K | -$19.1K | -$58.5K | -$636.7K | -$723.1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$534.4K | -$566.1K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$3.9K | |
Cash From Financing | $29.6M | $64.5M | $2.6M | $14.4M | $666.4K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.6M | $31.7M | -$19.3M | -$15.8M | $6.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$27M | -$32.7M | -$21.9M | -$30.2M | $6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.3M | -$8.4M | -$8M | -$6.8M | -$4.4M | |
Depreciation & Amoritzation | $6.4K | $5.2K | $9.5K | $10.8K | $158.1K | |
Stock-Based Compensation | $365.9K | $532.4K | $624.6K | $627.7K | $377.4K | |
Change in Accounts Receivable | $158.3K | -$584.5K | -$695.6K | -$436.5K | $124.8K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$8.4M | -$12.3M | -$16.1M | -$6.8M | -$5.5M | |
Capital Expenditures | -- | $4.6K | -- | $7.3K | $157.3K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$4.6K | -- | -$7.3K | -$157.3K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$200.4K | -$187.2K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$690 | -$2.5K | |
Cash From Financing | $11.4M | -- | $1.3M | $14K | $246.6K | |
Beginning Cash (CF) | $4.7M | $51.7M | $34.7M | $10.8M | $16M | |
Foreign Exchange Rate Adjustment | -$6.8K | -$9.2K | -$22K | -$39.2K | $13.1K | |
Additions / Reductions | $3M | -$12.3M | -$14.8M | -$6.8M | -$5.4M | |
Ending Cash (CF) | $7.7M | $39.3M | $19.8M | $4M | $10.6M | |
Levered Free Cash Flow | -$8.4M | -$12.3M | -$16.1M | -$6.8M | -$5.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.